NVDA$188.46 +2.10%
AAPL$260.77 +1.84%
TSLA$360.59 -2.46%
MSFT$389.24 +0.72%
AMZN$198.12 +1.33%
META$541.30 +0.88%
AMD$112.45 +2.91%
NFLX$95.20 +1.52%
GOOGL$162.34 -0.41%
TSM$178.90 +0.83%
ASML$724.50 +1.12%
SPY$661.20 +0.45%
QQQ$528.40 +0.54%
NVDA$188.46 +2.10%
AAPL$260.77 +1.84%
TSLA$360.59 -2.46%
MSFT$389.24 +0.72%
AMZN$198.12 +1.33%
META$541.30 +0.88%
AMD$112.45 +2.91%
NFLX$95.20 +1.52%
GOOGL$162.34 -0.41%
TSM$178.90 +0.83%
ASML$724.50 +1.12%
SPY$661.20 +0.45%
QQQ$528.40 +0.54%
CLOSED
HomeStock GuidesPATH
Technology / Robotic Process AutomationTechnical Analysis Guide
UiPath Inc. logo

PATH Stock Analysis

UiPath Inc.

💡 Quick Answer

Across 4 APEX technical signals, PATH is currently split between bullish and bearish readings0 bullish, 0 bearish as of 2026-06-11. Run a live analysis to see the current composite score.

PATH is an enterprise automation stock with ATR of 7-11%. Post-earnings moves of 12-18% are typical.

ARR Growth: Annual recurring revenue paceAI Agent Competition: Copilot and Agentforce threatRSI Behavior: Value-growth hybrid 35-65

UiPath is the leader in robotic process automation (RPA). Software robots that automate repetitive digital tasks like data entry, invoice processing, claims handling, and compliance reporting by mimicking human actions across legacy enterprise applications. Its Autopilot AI platform adds large language model capabilities on top of RPA, allowing enterprises to automate complex, judgment-based workflows beyond what rule-based robots can handle. UiPath serves 10,000+ enterprises across financial services, healthcare, manufacturing, and government.

LIVE CHART·PATH. DailyPowered by TradingView
Get live PATH signal analysis
APEX runs 8 signals on PATH in real time: RSI, MACD, Fibonacci, Volume, and more.
Analyze PATH Now →

Why Do Traders Watch PATH?

PATH is an enterprise automation stock with ATR of 7-11%. Post-earnings moves of 12-18% are typical. PATH faces a fundamental question: as AI agents (Salesforce Agentforce, ServiceNow AI, Microsoft Copilot) become more capable, will they displace RPA or augment it? UiPath's strategy is to position RPA and AI agents as complementary. RPA for structured automation, AI agents for unstructured tasks. ARR growth and enterprise customer expansion are the primary metrics traders track.

Is PATH a Buy Right Now? Current Signal Readings

📊ARR GrowthAnnual recurring revenue pace

PATH's ARR growth has decelerated from 40%+ in 2022 to 15-20% as the RPA market matures. ARR growth re-accelerating above 20%. Driven by Autopilot AI adoption on top of existing RPA deployments. Would be the signal that UiPath has successfully transitioned from pure RPA to AI+RPA, which commands a higher multiple and broader customer base.

🤖AI Agent CompetitionCopilot and Agentforce threat

The existential question for PATH is whether Microsoft Copilot, Salesforce Agentforce, and ServiceNow AI replace UiPath RPA or work alongside it. Management argues AI agents handle unstructured tasks while UiPath handles structured process automation. A complementary narrative. Track customer retention rates above 120% NRR and new customer adds in non-enterprise segments as the cleanest signal of whether this narrative is holding in the market.

📊RSI BehaviorValue-growth hybrid 35-65

PATH's RSI has been suppressed relative to software peers due to competitive uncertainty from AI agents. RSI recovering above 55. Sustained for 3+ weeks following an ARR re-acceleration quarter. Would signal the market is pricing in UiPath's AI+RPA thesis rather than displacement risk, enabling a multiple re-rating toward SaaS software peers.

📊NRR MetricNet revenue retention health

UiPath's Net Revenue Retention (NRR). Measuring revenue from the existing customer base including expansions minus churn. Is the key indicator of whether existing customers are deploying more automation or reducing RPA usage. NRR above 120% confirms expansion-led growth; below 110% suggests customers are consolidating licenses rather than expanding. This metric is PATH's clearest fundamental signal.

📋 PATH Key Stats for Traders

ATR (14-day)7-11% of price
📦Avg daily volume~5-10 million shares
🎯Key metricARR growth + NRR above 120%
📅Post-earnings move12-18% typical

🔗 Related Stocks

Run a live PATH analysis

APEX combines RSI, MACD, Fibonacci, Volume, and 4 more signals into one composite score in under 30 seconds.

Analyze PATH Free →
📊 Advanced charting for PATH on TradingView ↗

💬 Frequently Asked Questions. PATH

QIs PATH a good stock to buy right now?
AWhether PATH is a buy depends on its current technical positioning. PATH is an enterprise automation stock with ATR of 7-11%. Post-earnings moves of 12-18% are typical. PATH faces a fundamental question: as AI agents (Salesforce Agentforce, ServiceNow AI, Microsoft Copilot) become more capable, will they displace RPA or augment it? UiPath's strategy is to position RPA and AI agents as complementary. RPA for structured automation, AI agents for unstructured tasks. ARR growth and enterprise customer expansion are the primary metrics traders track. Run a live APEX analysis at apexstockintel.com to see the current composite score, RSI, and MACD signals. Updated every trading day.
QWhat are the most important technical signals for PATH?
AThe four key signals for PATH are: ARR Growth (Annual recurring revenue pace). PATH's ARR growth has decelerated from 40%+ in 2022 to 15-20% as the RPA market matures. ARR growth re-accelerating above 20%. Driven by Autopilot AI adoption on top of existing RPA deployments. Would be the signal that UiPath has successfully transitioned from pure RPA to AI+RPA, which commands a higher multiple and broader customer base.. AI Agent Competition (Copilot and Agentforce threat). The existential question for PATH is whether Microsoft Copilot, Salesforce Agentforce, and ServiceNow AI replace UiPath RPA or work alongside it. Management argues AI agents handle unstructured tasks while UiPath handles structured process automation. A complementary narrative. Track customer retention rates above 120% NRR and new customer adds in non-enterprise segments as the cleanest signal of whether this narrative is holding in the market.. RSI Behavior (Value-growth hybrid 35-65). PATH's RSI has been suppressed relative to software peers due to competitive uncertainty from AI agents. RSI recovering above 55. Sustained for 3+ weeks following an ARR re-acceleration quarter. Would signal the market is pricing in UiPath's AI+RPA thesis rather than displacement risk, enabling a multiple re-rating toward SaaS software peers.. NRR Metric (Net revenue retention health). UiPath's Net Revenue Retention (NRR). Measuring revenue from the existing customer base including expansions minus churn. Is the key indicator of whether existing customers are deploying more automation or reducing RPA usage. NRR above 120% confirms expansion-led growth; below 110% suggests customers are consolidating licenses rather than expanding. This metric is PATH's clearest fundamental signal.
QWhat is PATH's RSI telling traders right now?
APATH's RSI has been suppressed relative to software peers due to competitive uncertainty from AI agents. RSI recovering above 55. Sustained for 3+ weeks following an ARR re-acceleration quarter. Would signal the market is pricing in UiPath's AI+RPA thesis rather than displacement risk, enabling a multiple re-rating toward SaaS software peers. APEX scores PATH's RSI as part of its 8-factor composite signal. Updated daily.
QHow does PATH behave technically compared to other Technology / Robotic Process Automation stocks?
APATH is in the Technology / Robotic Process Automation sector. UiPath is the leader in robotic process automation (RPA). Software robots that automate repetitive digital tasks like data entry, invoice processing, claims handling, and compliance reporting by mimicking human actions across legacy enterprise applications. Its Autopilot AI platform adds large language model capabilities on top of RPA, allowing enterprises to automate complex, judgment-based workflows beyond what rule-based robots can handle. UiPath serves 10,000+ enterprises across financial services, healthcare, manufacturing, and government. Key stats: ATR (14-day): 7-11% of price, Avg daily volume: ~5-10 million shares, Key metric: ARR growth + NRR above 120%, Post-earnings move: 12-18% typical.
QWhat MACD signals work best for PATH?
AMACD measures momentum direction via the relationship between two exponential moving averages. Bullish crossovers (MACD line crossing above the signal line) indicate increasing upward momentum, while bearish crossovers signal the opposite. APEX tracks PATH's MACD histogram direction daily.
OTHER STOCK GUIDES
Technology48
+
Comm Services18
+
Financials34
+
Consumer Disc.40
+
Consumer Staples14
+
Industrials21
+
Materials12
+
Energy19
+
Health Care25
+
Real Estate12
+
Utilities15
+
ETFs & Indexes23
+
My Edge
Analyze
Heat Map
Account